The report maintains an ADD rating but trims the target price from Rs 1,375 to Rs 1,365 along with minor downward revisions to EPS estimates, using an SOTP valuation approach.
Read this note →Research notes
What India's research desks published, reported with attribution and linked to the original notes. Orivam issues no recommendations of its own.
All houses
HDFC Securities
Motilal Oswal
Tata Asset Management
Mirae Asset Sharekhan
Jainam
India IPO
GEPL Capital
Way2Wealth
SBICAP Securities
Angel One
Axis Securities
ICICI Direct Research Retail
Formerly known as Way2Wealth
Religare
Arete Securities
ICICI Direct
Way2Wealth Securities
ICICI Securities
quant Mutual Fund
Kotak Securities
JM Financial
ICICI Securities – Retail
Ventura Securities
Global Markets by Vested
Prabhudas Lilladher
ITC Hotels
Elara Securities
Exterminators PLC
Emkay Global
Industrial Asphalts
Private Client Group Research summarized from KIE research report
Kahawatte Plantations PLC
1793 notes · 01 Oct 2026, 00:00 to 01 Nov 2026, 00:00 IST
The report upgrades the rating from ADD to BUY while keeping the target price unchanged at Rs 400 and EPS estimates unchanged.
Read this note →The report maintains a REDUCE rating with an unchanged target price of Rs 580 and unchanged EPS estimates.
Read this note →The report maintains a BUY rating but cuts the target price from Rs 925 to Rs 790, lowering the target P/E multiple from 28x to 25x and trimming EPS estimates to reflect near-term margin pressures and potential impact of price hikes on consumer affordability.
Read this note →The report maintains a BUY rating with an unchanged target price of Rs 225 and unchanged EPS estimates.
Read this note →The report maintains a REDUCE rating with an unchanged target price of Rs 1,530 and unchanged EPS estimates.
Read this note →The report maintains an ADD rating with an unchanged target price of Rs 1,245 and broadly unchanged EPS estimates, expecting strong Q2FY27 revenue growth of 27.6% YoY.
Read this note →The report maintains a BUY rating but cuts the target price from Rs 640 to Rs 570, lowering the target P/E multiple from 38x to 35x and trimming EPS estimates to reflect near-term margin pressures and potential impact of price hikes on consumer affordability.
Read this note →The report maintains a BUY rating with an unchanged target price of Rs 320 and no change in EPS estimates.
Read this note →The report maintains a REDUCE rating with an unchanged target price of Rs 320 and no change in EPS estimates.
Read this note →The note reports that Swara Baby Products received SEBI approval for its proposed Rs 1,000 crore IPO.
Read this note →The note reports that Marico increased its stake in the parent company of Plix to 84%, deepening its presence in the health and wellness sector.
Read this note →Listed as an intraday quant sell idea at close price 2,101 with 1% stop loss and 1% target.
Read this note →Listed as an intraday quant sell idea at close price 109 with 1% stop loss and 1% target.
Read this note →The derivatives section lists a MUTHOOTFIN 2700 PE buy citing short build-up.
Read this note →The derivatives section lists a MAXHEALTH 900 PE buy citing short build-up.
Read this note →The derivatives section lists a HYUNDAI 1980 PE buy citing short build-up.
Read this note →Included in the EV basket at 20% weight, and a SONACOMS 830 CE buy is listed on long build-up.
Read this note →Included at 20% weight in the note's 12-month EV value chain basket.
Read this note →Included at 20% weight in the note's 12-month EV value chain basket.
Read this note →Included at 20% weight in the note's 12-month EV value chain basket.
Read this note →Included at 20% weight in the note's 12-month EV value chain basket targeting 15-20% upside.
Read this note →Listed among one-year focus investment ideas at CMP Rs 683 with 16% upside.
Read this note →Listed among one-year focus investment ideas at CMP Rs 1,685 with 18% upside.
Read this note →Listed among one-year focus investment ideas at CMP Rs 1,927 with 20% upside.
Read this note →